News

Avacta Group plc and LG Chem Life Sciences announced a multi-target collaboration and development agreement. The agreement provides LG Chem with the exclusive rights to develop and…
Read More...

Berkeley Lights, Inc. and Novo Nordisk announced that Novo Nordisk has purchased the Beacon® Optofluidic platform to accelerate workflows in cell line development and to use the…
Read More...

Eli Lilly and Company and AC Immune SA announced that the two companies have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small…
Read More...

X-Chem, Inc., a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, announced a drug discovery…
Read More...

Black Diamond Therapeutics, a biotechnology company developing a new type of precision medicine for cancer, came out of stealth mode today with a $20 million Series A financing…
Read More...

Schrödinger and TB Alliance announced a three-year research collaboration to speed the development of next-generation tuberculosis (TB) treatments by leveraging Schrödinger’s advanced…
Read More...

InveniAI Corporation announced that it has entered a collaboration agreement with Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) to harness the power of AI and ML for drug discovery.…
Read More...

Cambrex Corporation announced that it is investing $1 million at its High Point, NC site to fit out 1,300 sq. ft. of analytical laboratory space and plans to hire 9 chemical research…
Read More...

Amgen announced a novel multi-year collaboration with Magellan Rx Management, the pharmacy benefit management division of Magellan Health, that will leverage each company's capabilities…
Read More...

Vect-Horus announced the signing of a research collaboration agreement with Janssen Pharmaceuticals, Inc. one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The goal…
Read More...

Alnylam Pharmaceuticals announced that it has resolved all litigation worldwide with Silence Therapeutics. The settlement allows Alnylam to avoid the costs and distraction associated…
Read More...

SGS announced that it is investing €3.5 million to undertake a two-phase expansion project at its laboratory in Poitiers, France, to implement a 50% increase in bioanalytical…
Read More...

WuXi AppTec announces the expansion of its facilities in San Diego, California. WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery…
Read More...

HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Mitsubishi Tanabe Pharma Corporation to identify novel small molecule leads for…
Read More...

GeneCentric Therapeutics announced that it has entered into a research collaboration with the University of North Carolina at Chapel Hill (UNC) to assess patient response to…
Read More...

WuXi Biologics and Oxford BioTherapeutics announced the expansion of their strategic and innovative immuno-oncology (IO) alliance through which OBT will research, develop and…
Read More...

Gilead Sciences announced that its Board of Directors has named Daniel O’Day Chairman of the Board and Chief Executive Officer, effective March 1, 2019. Mr. O’Day is currently the CEO…
Read More...

AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed at accelerating…
Read More...

Bristol-Myers Squibb Company and Vedanta Biosciences announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's programmed death-1 (PD-1) immune checkpoint inhibitor…
Read More...

Pharmaceutical Product Development, LLC (PPD) is adding gene and cell therapy analytical testing to its GMP (good manufacturing practices) laboratory in Athlone, Ireland, to support the…
Read More...